Hikma Pharmaceuticals, Societe de Promotion Pharmaceutique du Maghreb S.A. deal

Hikma acquired a 63.9% stake in the pharmaceutical manufacturing company for $111.2 million and plans to launch a mandatory tender offer to acquire the remaining 36.1%. Hikma expects to complete the tender offer by the end of the year. ...